Navigation Links
Astellas Launches Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
Date:4/1/2009

eatment of congestive heart failure. It should only be used for the treatment of hyponatremia in patients with underlying heart failure when the expected benefit of raising serum sodium outweighs the increased risk of adverse events. Vaprisol is contraindicated in patients with hypovolemic hyponatremia. In addition, coadministration of Vaprisol with potent CYP3A4 inhibitors, such as ketoconazole, itraconazole, clarithromycin, ritanovir, and indinavir, is contraindicated. Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products. Serum sodium, volume, and neurological status must be monitored frequently because Vaprisol potentially can cause overly rapid correction of sodium leading to serious sequelae. The use of Vaprisol in patients with hepatic impairment (including ascites, cirrhosis, or portal hypertension) or renal impairment has not been systematically evaluated. Use caution when administering Vaprisol to these patients. The most common adverse reactions reported were infusion site reactions (incidence of 73% and 63% for 20 mg/day and 40 mg/day respectively) which were also the most common type of adverse reaction leading to discontinuation of Vaprisol. Discontinuations from treatment due to infusion site reactions were more common among Vaprisol-treated patients (3%) than among placebo-treated patients (0%). Other common adverse reactions were headaches (8%, 10%), hypokalemia (22%, 10%), orthostatic hypotension (14%, 6%), and pyrexia (11%, 5%) for Vaprisol 20mg/day and 40mg/day, respectively.(1) For full prescribing information, please visit www.Vaprisol.com.

About Astellas

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a US affiliate of Tokyo-based Astellas Pharma Inc., Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innov
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cardiome And Astellas Announce Regulatory Update
2. FDA Approves Additional Indication for Astellas MYCAMINE(R)
3. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence
4. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
5. UPMC Health Plan Launches New Personal Health Record
6. HealthInsuranceFinders.com Launches Video Contest for Young Directors
7. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
8. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
9. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
10. Mannatech Launches Phase One of New Sales and Training Tools
11. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Atlanta-based Jvion, a leader in clinical predictive algorithms ... predictive population health analytics as part of an ongoing ... healthcare. Ritesh Sharma, Jvion COO, commented, “it is critical ... the impact of and potential within predictive analytics. There ... good portion of it is conflicting or confusing. The ...
(Date:7/31/2014)... July 31, 2014 The rising population ... factor driving the global geriatric care services market wherein ... supply of these services across the globe. There are ... home care agency to few large companies with national ... is underserved and is also highly fragmented. The developed ...
(Date:7/31/2014)... the winter of 1944, the Nazis blocked food supplies ... famine and devastation. The impact of starvation on expectant ... changes resulting from external rather than genetic influences ... hardship could be inherited. The underlying mechanism, however, remained ... in the journal Cell , Dr. Oded Rechavi, ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The ... (Column based, Reagent based, Magnetic bead based), Consumables ... isolation, Total RNA isolation), End users - Global ... the major drivers, restraints, challenges, opportunities, current market ... isolation and purification market along with the estimates ...
(Date:7/31/2014)... Global Markets , Brain Cancer - ... the Brain Cancers therapeutic pipeline. , This report ... Brain Cancer, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ... and press releases. It also reviews key players ...
Breaking Medicine News(10 mins):Health News:Jvion Releases Top Three Lessons in Predictive Population Health Analytics 2Health News:Jvion Releases Top Three Lessons in Predictive Population Health Analytics 3Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 2Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 3Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 4Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 5Health News:The 'memory' of starvation is in your genes 2Health News:The 'memory' of starvation is in your genes 3Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 2Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 3Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 4
... relationship between language functioning and schizophrenia, and verbal ... significantly negative consequences for real world social functioning. ... some forms of memory are selectively impaired in ... contextual verbal memory impairment that may be associated ...
... knows - Women feel more pain than men.// ,The ... them to feel pain more intensely than men. According to researcher ... women averaged 34 nerve fibres per square centimetre of facial skin ... of the US population suffers from acute pain and 25 ...
... of Pittsburgh have successfully treated heart failure in an animal ... dystrophy. The article detailing this study is published in the ... that this is the first time that a gene therapy ... author, Xiao Xiao, Ph.D., associate professor of orthopedic surgery at ...
... type of histories all the time. Now for the first ... boy after one of them was left infertile after she ... from Woolwich in southeast London was declared infertile and her ... their eldest sister carried the fetus in her womb to ...
... is produced from the leaves of the evergreen plant ... tea are polyphenolic compounds, known as catechins. Catechins of ... // ht, including (-)-epigallocatechin gallate (EGCG), (-)-epigallocatechin (EGC), ... for approximately 50% of the total amounts of catechins ...
... pluripotent hematopoietic stem cell disorder characterized by accumulation of ... marrow due to uncontrolled growth // and resistance ... tyrosine kinase, which is encoded by the bcr?abl fusion ... malignant phenotypes. , ,Gleevec, which is an inhibitor ...
Cached Medicine News:Health News:Prose Memory Deficits Found To Be Associated With Schizophrenia 2Health News:Gene Therapy Overcomes Heart Failure In Muscular Dystrophy 2Health News:Catechins in green tea show antiviral effect on influenza virus 2Health News:The potent anti-leukemia activity of Berbamine 2
(Date:7/31/2014)... TB Alliance, a not-for-profit with the ... affordable treatments, announced the appointment of Willo ... Mr. Brock comes to TB Alliance having most ... for WWF International (formerly known as the World ... guide the TB Alliance,s resource development, advocacy and ...
(Date:7/31/2014)... NEW YORK und KISSING, Deutschland, ... ein Hersteller und Distributor eines computerunterstützten („robotischen") ... Nachum (Homi) Shamir , ein weltweit ... seines Leitungs- und Kontrollgremiums zum Unternehmen stößt. ... Shamir ist ein hochangesehener ...
(Date:7/31/2014)... Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or ... branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), ... the signing of its first distributor for its new ... Hubei Province located in ... . The contract with the new ...
Breaking Medicine Technology:TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 3Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 4
... 14, 2012  Nephros, Inc. (OTC Bulletin Board: ... filtration products for therapeutic applications, infection control, and water ... Sullivan as Director of U.S. Sales. Mr. ... leadership role in the healthcare, life science and biopharmaceutical ...
... HealthCare Pharmaceuticals Inc. today announced that the U.S. Food ... for Natazia® (estradiol valerate and estradiol valerate/dienogest) tablets for ... not caused by any diagnosed conditions of the uterus ... for contraception.  With this approval, Natazia is the first ...
Cached Medicine Technology:Nephros Hires Director of U.S. Sales 2Nephros Hires Director of U.S. Sales 3Nephros Hires Director of U.S. Sales 4Nephros Hires Director of U.S. Sales 5Nephros Hires Director of U.S. Sales 6U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB) 2U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB) 3U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB) 4
... injection of contrast medium, anesthetic gel, and/or ... eliminates the need for multiple catheterizations. The ... passage into and through the ureter. AQ ... that when activated, attracts and holds water ...
Used for drainage and retrograde pyelogram. Supplied sterile in peel-open packages. Intended for one-time use....
... The whistle tip has two ... plastic and the Luer fitting adapter ... for identification of left or right. ... sterile and x-ray opaque. The length ...
Used for directing a flexible tipped wire guide in the ureter. The angled tip allows passage of the catheter past a ureteral stone in preparation for E.S.W.L. Supplied sterile in peel-open packages. ...
Medicine Products: